| Nimi | Vol. | Hinta | |
|---|---|---|---|
NOVOb Novo Nordisk A/S Class B | 2,23M | 668,60+0,36% | 08/12 |
EKTAb Elekta | 1,07M | 84,14+1,35% | 08/12 |
AMBUb Ambu B | 1,04M | 94,90+3,09% | 08/12 |
SOBIV Swedish Orphan Biovitrum | 808,38K | 239,40-1,07% | 08/12 |
GETIb Getinge | 644,08K | 232,00+0,39% | 08/12 |
| Nimi | Hinta | |
|---|---|---|
AMBUb Ambu B | 94,90 | +2,8 | +3,09%
DEMANT Demant | 293,20 | +6,8 | +2,37%
GMAB Genmab | 2.252,00 | +42,0 | +1,90%
EKTAb Elekta | 84,14 | +1,12 | +1,35%
ORNBV Orion B | 36,60 | +0,36 | +0,99%
| Nimi | Hinta | |
|---|---|---|
COLOb Coloplast | 767,40 | -8,8 | -1,13%
SOBIV Swedish Orphan Biovitrum | 239,40 | -2,60 | -1,07%
GN Gn Store Nord | 160,30 | -0,9 | -0,53%
CHRH Chr Hansen | 550,40 | -1,0 | -0,18%
NZYMb Novozymes B | 360,30 | -0,3 | -0,08%